• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES TF NF3 DEL SYS, 29MM, COM; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES TF NF3 DEL SYS, 29MM, COM; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9355FS29
Device Problems Malposition of Device (2616); Positioning Problem (3009)
Patient Problem Injury (2348)
Event Date 04/28/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).This is one of two manufacturer reports being submitted for this case.The report represents the first valve used.Difficulty tracking the delivery system (ds) through the vasculature may be due to anatomical and/or procedural factors, including tortuous vessels, previously implanted stents and/or grafts, wire bias, and kinked ds.In most instances this resolves with routine troubleshooting maneuvers, with minimal risk to the patient.In severe cases, if the delivery system cannot track to the native annulus, the valve may be deployed in a non-target location, or retracted and removed through a surgical cutdown.The thv training manuals instruct the operator on proper positioning and deployment of the valve, including all procedural and anatomical considerations.Physicians are extensively trained by edwards before they are qualified to use the sapien thv.Training includes patient screening, device preparation, approach, deployment, imaging, procedure-specific training manuals and proctored procedures.The correct alignment and positioning of the device at the point of deployment is emphasized as a key factor to the placement and fixation of the device.There may be cases in which the valve is not able to be deployed at the intended location.This may require deploying the valve at a non-target location.Although, generally well tolerated, the long term effects are not completely understood.In this case, there was no allegation or indication a device malfunction contributed to this adverse event.Investigation results suggest/indicate the patient¿s anatomy contributed to the tracking difficulty and resulting valve placement at a non-target location.Device deployment in unintended location is listed in the ifu.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Event Description
As reported by our affiliates in (b)(4), during implant of a 29mm sapien xt valve in the pulmonic position via transvenous approach, there was difficulty crossing the pulmonic valve due to a malformations/hardness in the patient anatomy after several previous interventions.After several maneuvers with pods of different types, including the use of a loop to try to position the valve correctly, the attempt was aborted.The valve was implanted in the mouth of the inferior vena cava.Access was then attempted with a second valve via the jugular vein.The access route had a smaller distance, but was more complex.The patient began to decompensate and had an abrupt decrease in blood pressure, therefore, the procedure was aborted.The valve was implanted at the mouth of the superior vena cava.
 
Manufacturer Narrative
Please reference related manufacturer report no: 2015691-2018-00798.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TF NF3 DEL SYS, 29MM, COM
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
frances preston
1 edwards way
irvine, CA 92614
9492505190
MDR Report Key7322379
MDR Text Key101833540
Report Number2015691-2018-00797
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
Reporter Country CodeAR
PMA/PMN Number
P130009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/30/2018
Device Model Number9355FS29
Device Lot Number60339531
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/07/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
-
-